STR profiling in a cohort of Saudi patients with acute leukemia.

Husein A Alhatim, Muhammad Nh Abdullah, Suhaili A Jamaludin, Armania B Nurdin, Sayed A Amer
Author Information
  1. Husein A Alhatim: Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, UPM Serdang, Malaysia.
  2. Muhammad Nh Abdullah: Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, UPM Serdang, Malaysia.
  3. Suhaili A Jamaludin: Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, UPM Serdang, Malaysia.
  4. Armania B Nurdin: Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, UPM Serdang, Malaysia.
  5. Sayed A Amer: Department of Forensic Sciences, College of Criminal Justice, Naif Arab University for Security Sciences, KSA.

Abstract

Objective: This study was aimed at characterizing whether the autosomal short tandem repeats (STRs) used in forensic identification might differ between leukemic blood samples and saliva samples.
Methods: Blood and saliva samples were collected from 27 patients diagnosed with acute leukemia in Riyadh City, KSA. DNA was extracted, and 15 STR loci were amplified.
Results: Approximately 59.3% of patients with leukemia exhibited mutations at the STR loci. Loss of heterozygosity (LOH) occurred in 40.7% of the patients at D19S433, D16S539, vWA, D13S317, TH01, FGA, and D2S1338. Microsatellite instability (MSI) was detected in 22.2% of patients at TPOX, vWA, D19S433, D16S539, and D18S51. D19S433 and D16S539 were the most affected loci, exhibiting an alteration percentage of 18.52%, followed by vWA (11.11%); in contrast, D2S1338, D18S51, and TPOX were the least affected loci, showing a mutation percentage of 3.7%. D13S317, TH01, and FGA showed moderate genetic mutation (7.41%). CSF1PO, D21S11, D3S1358, D5S818, D7S820, D8S1179, and amelogenin did not show genetic changes in all samples. The overall genetic variability between saliva and blood samples significantly differed ( < 0.001).
Conclusion: Our results demonstrate the potential application of forensically used STR loci in diagnosis and monitoring of patients with leukemia. Further study applying next generation sequencing technology is necessary to validate these findings and explore the clinical applications of forensically used STRs as diagnostic tools for leukemia.

Keywords

References

  1. Forensic Sci Int Genet. 2017 Sep;30:148-151 [PMID: 28743032]
  2. Cancer Cell Int. 2019 Apr 29;19:113 [PMID: 31168295]
  3. Cancer Metastasis Rev. 2013 Dec;32(3-4):341-52 [PMID: 23633034]
  4. BMC Cancer. 2019 Jul 17;19(1):703 [PMID: 31315607]
  5. Genome Biol. 2003;4(2):R13 [PMID: 12620123]
  6. Clinics (Sao Paulo). 2012 Oct;67(10):1181-90 [PMID: 23070345]
  7. Mol Biol Rep. 2014 Jun;41(6):3961-72 [PMID: 24562624]
  8. Genome Res. 2020 Mar 24;: [PMID: 32209592]
  9. Genes (Basel). 2021 Jan 29;12(2): [PMID: 33572856]
  10. Indian J Cancer. 2017 Apr-Jun;54(2):426-429 [PMID: 29469071]
  11. Medicina (Kaunas). 2021 Mar 02;57(3): [PMID: 33801242]
  12. Life Sci. 1997;61(14):1341-7 [PMID: 9335223]
  13. Leuk Res. 2001 Jan;25(1):39-43 [PMID: 11137559]
  14. Genes (Basel). 2022 Mar 25;13(4): [PMID: 35456396]
  15. Gene. 2018 Oct 5;673:107-111 [PMID: 29913241]
  16. Cureus. 2022 Nov 1;14(11):e30954 [PMID: 36465210]
  17. Nature. 2023 Jan;613(7942):96-102 [PMID: 36517591]
  18. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Jun;29(3):306-8 [PMID: 22678796]
  19. Cancer Manag Res. 2022 Feb 15;14:547-559 [PMID: 35210852]
  20. Front Genet. 2020 Aug 06;11:884 [PMID: 32849844]
  21. Arch Toxicol. 2015 Jun;89(6):899-921 [PMID: 25701956]
  22. Mol Genet Genomic Med. 2020 Apr;8(4):e1164 [PMID: 32043756]
  23. Hum Immunol. 2011 Jun;72(6):503-9 [PMID: 21463659]
  24. Gene. 2014 Apr 25;540(1):32-6 [PMID: 24582974]
  25. Genes (Basel). 2023 Feb 24;14(3): [PMID: 36980843]
  26. Int J Legal Med. 2011 May;125(3):327-32 [PMID: 20369250]
  27. Am J Surg. 2007 Sep;194(3):380-4 [PMID: 17693286]
  28. Leg Med (Tokyo). 2018 Jan;30:38-41 [PMID: 29154002]
  29. Leukemia. 2017 Jun;31(6):1474-1476 [PMID: 28336936]
  30. Genes Chromosomes Cancer. 2014 Dec;53(12):1008-17 [PMID: 25183446]
  31. Proc Natl Acad Sci U S A. 2022 Oct 4;119(40):e2121024119 [PMID: 36166477]
  32. Saudi Med J. 2024 Mar;45(3):295-306 [PMID: 38438211]
  33. Genet Test. 2007 Winter;11(4):397-400 [PMID: 18294056]
  34. Asian Pac J Cancer Prev. 2021 Sep 01;22(9):2797-2806 [PMID: 34582648]

Word Cloud

Created with Highcharts 10.0.0patientssamplesleukemiaSTRlociusedsalivaD19S433D16S539vWAmutationgeneticstudySTRsbloodacute7%D13S317TH01FGAD2S1338TPOXD18S51affectedpercentageforensicallydiagnosisSaudiObjective:aimedcharacterizingwhetherautosomalshorttandemrepeatsforensicidentificationmightdifferleukemicMethods:Bloodcollected27diagnosedRiyadhCityKSADNAextracted15amplifiedResults:Approximately593%exhibitedmutationsLossheterozygosityLOHoccurred40MicrosatelliteinstabilityMSIdetected222%exhibitingalteration1852%followed1111%contrastleastshowing3showedmoderate741%CSF1POD21S11D3S1358D5S818D7S820D8S1179amelogeninshowchangesoverallvariabilitysignificantlydiffered< 0001Conclusion:resultsdemonstratepotentialapplicationmonitoringapplyingnextgenerationsequencingtechnologynecessaryvalidatefindingsexploreclinicalapplicationsdiagnostictoolsprofilingcohortGeneticLeukemiaMoleculargenotypingpopulation

Similar Articles

Cited By